跳至主要内容
临床试验/NCT02560597
NCT02560597终止不适用

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy - Case Study in Patients With Epilepsia Partialis Continua (EPC) and Refractory Status Epilepticus (SE)

University Hospital, Ghent2 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2015年2月3日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
4
试验地点
2
主要终点
Seizure diary

研究概览

简要总结

The purpose of this study is to assess the effects of repetitive transcranial magnetic stimulation (rTMS) as a treatment for Epilepsia Partialis Continua (EPC) or refractory Status Epilepticus (SE), when standard clinical treatments have failed.

详细描述

  1. Study design:

This is a case study, including up to 10 patients with EPC or refractory SE that are admitted to the service in the coming 5 years.

If circumstances permit so, a baseline evaluation of seizure frequency over 1 week and a 24-hour baseline EEG registration will be obtained, as well as a baseline clinical neurologic exam. In case of therapeutic urgency, these baseline measurements will be omitted.

The treatment itself consists of multiple stimulation sessions over multiple days, decided upon based on patient characteristics and the obtained effects. In absence of the desired effect, treatment will be repeated during 5 consecutive days at most.

Patients will be followed-up clinically and electrographically. In case of therapeutic success, the treatment can be repeated over time when seizures reoccur. 2. Objectives:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Epilepsia partialis continua or refractory status epilepticus
  • Prior investigations (EEG, MRI...) show a well-defined neocortical epileptogenic focus
  • Informed consent signed by the patient or his/her legal representative

排除标准

  • Pregnancy, short-term birth wish or childbearing age without adequate birth control
  • Intracranial metal hardware (excluding dental filling): surgical clips, shrapnell, electrodes under the stimulation area
  • Presence of pacemaker, implantable cardioverter-defibrillator (ICD), permanent medication pumps, cochlear implants or deep brain stimulation (DBS)

结局指标

主要结局

Seizure diary

时间窗: Throughout the study, lasting approximately 4 weeks

Self-reported seizure frequency throughout the study as a measure of clinical efficacy.

Electrographic epileptiform activity

时间窗: Throughout the study, lasting approximately 4 weeks, with assessment before treatment (if possible) and after treatment

Interictal or continuous epileptiform activity on EEG is assessed throughout the study as a measure of clinical efficacy.

Neurological examination

时间窗: Throughout the study, lasting approximately 4 weeks

Neurological examination assessing consciousness and other cortical functions that are potentially disturbed by the EPC or SE (eg. motor function, speech,...) is performed throughout the study as a measure of clinical efficacy.

次要结局

  • Duration of the clinical effect(Throughout the study, lasting approximately 4 weeks or as long as the outlasting effect lasts)
  • Adverse events(Throughout the study, lasting approximately 4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. Kristl Vonck

Prof. Dr. Boon

University Hospital, Ghent

研究点 (2)

Loading locations...

相似试验